Brad Ringeisen
Company: Innovative Genomics Initiative
Job title: Executive Director
Seminars:
Morning Workshop: Expanding Rare Disease Targeting Using Lessons Learned from Baby KJ’s Personalized CRISPR Therapy 9:30 am
Following the groundbreaking work to launch the world's first personalized CRISPR therapy to treat baby KJ, a new blueprint for rare disease treatment is forming. This interactive workshop with the baby KJ team offers unmissable insights into how this pioneering approach to precision medicine has created a transformative model for targeting rare diseases more effectively…Read more
day: Day Two
Panel Discussion: Driving Collaborations to Unlock New Therapeutic Opportunities 8:30 am
Evaluate partnerships between pharma and biotech companies and the impact academia can have on the development of genome editing therapies Discuss the ideal criteria for company collaborations and investment to improve discovery efficiency Highlight key strategies from successful collaborations to direct and refine future collaborative effortsRead more
day: Day Two
The Future: How Baby KJ’s Personalized CRISPR Therapy Will Facilitate Better Rare Disease Targeting 9:35 am
Following the groundbreaking work to launch the world’s first personalized CRISPR therapy to treat baby KJ, a new blueprint for rare disease treatment is forming. With the baby KJ team swiftly adapting base editing technology, rapidly co-ordinating regulatory approval and redefining clinical strategies, this session offers an unmissable insight into how this pioneering approach to…Read more
day: Pre-Conference Workshop Day
Chair’s Opening Remarks 7:50 am
day: Day One AM